Bevacizumab and pyrexia Patient Reports February 10, 2012

Bevacizumab Side Effects Report #5275487-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Male patient, 71 years of age, weighting 177.0 lb, was diagnosed with tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bevacizumab dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5328101-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 16, 2007. Female patient, weighting 158.0 lb, was diagnosed with squamous cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dysphagia, pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL, RADIATION. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5350091-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 05, 2007. Female patient, weighting 158.0 lb, was diagnosed with squamous cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dysphagia, pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL, RADIATION. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5400528-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 24, 2007. Female patient, weighting 158.0 lb, was diagnosed with squamous cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: oesophagitis, pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL, RADIATION. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5807606-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 02, 2008. Female patient, weighting 160.3 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, pyrexia, staphylococcal bacteraemia. Bevacizumab dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, METHYLPHENIDATE, HYDROCODONE, TYLENOL PM, ESOMEPRAZOLE MAGNESIUM, ESCITALOPRAM, ALPRAZOLAM, POTASSIUM PHOSPHATE MONOBASIC. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5914027-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 29, 2008. Female patient, weighting 160.3 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, METHYLPHENIDATE, HYDROCODONE BITARTRATE, TYLENOL, ESOMEPRAZOLE MAGNESIUM, ESCITALOPRAM, ALPRAZOLAM, POTASSIUM PHOSPHATE MONOBASIC. Patient recovered.

Bevacizumab Side Effects Report #5924253-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 08, 2008. Female patient, weighting 160.3 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, METHYLPHENIDATE, HYDROCODONE BITARTRATE, TYLENOL, ESOMEPRAZOLE MAGNESIUM, ESCITALOPRAM, ALPRAZOLAM, POTASSIUM PHOSPHATE MONOBASIC. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5967782-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 18, 2008. Female patient, weighting 160.3 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, METHYLPHENIDATE, HYDROCODONE BITARTRATE, TYLENOL, ESOMEPRAZOLE MAGNESIUM, ESCITALOPRAM, ALPRAZOLAM, POTASSIUM PHOSPHATE MONOBASIC. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5224744-7
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 29, 2007. Male patient, 72 years of age, weighting 186.0 lb, was diagnosed with prostate cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, chills, dehydration, fatigue, mucosal inflammation, myalgia, nausea , pyrexia, unevaluable event. Bevacizumab dosage: 455 MG X1 IV. During the same period patient was treated with DOCETAXEL, CHEMO, LISINOPRIL, POTASSIUM ACETATE, FERROS GLUCONATE, FUROSEMIDE, GLYBURIDE, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5301949-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 16, 2007. Male patient, weighting 220.0 lb, was diagnosed with prostate cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dizziness , dyspnoea exertional, dysstasia, faeces discoloured, nausea , presyncope, pyrexia. Bevacizumab dosage: 1500 MG Q THREE WEEKS IV DRIP. During the same period patient was treated with ERLOTINIB, AVASTIN, TAXOTERE, PREDNISONE, TARCEVA, ACTOPLUS, ASPIRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5927205-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 15, 2008. Male patient, weighting 223.8 lb, was diagnosed with prostate cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with TAXOTERE, LUPRON, ASPIRIN, ZOMETA, TYLENOL. Patient recovered.

Bevacizumab Side Effects Report #5043213-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2006. Male patient, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, dyspnoea, enteritis, febrile neutropenia, pyrexia, small intestinal obstruction. Bevacizumab dosage: 400 MG QS Q2WEEKS IV. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, VICODIN, IMODIUM. Patient recovered.

Bevacizumab Side Effects Report #6060382-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 30, 2009. Male patient, 70 years of age, weighting 191.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , device breakage, device migration, enterocolitis infectious, large intestine perforation, post procedural discomfort, pyrexia. Bevacizumab dosage: 690MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5164856-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 10, 2006. Female patient, 63 years of age, weighting 149.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, diffuse alveolar damage, lethargy, malaise, metabolic acidosis, pyrexia, sinus tachycardia. Bevacizumab dosage: 340 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ERLOTINIB, GEMCITABINE, LISINOPRIL, DICLOFENAC, ACETAMINOPHEN. Patient was hospitalized. Patient died on 03/10/2006.


Bevacizumab Side Effects Report #4999871-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 21, 2006. Female patient, 63 years of age, weighting 149.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, diffuse alveolar damage, hypertension, lethargy, metabolic acidosis, pyrexia, sinus tachycardia. Bevacizumab dosage: 340 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ERLOTINIB, GEMCITABINE, LISINOPRIL. Patient was hospitalized. Patient died on 03/10/2006.

Bevacizumab Side Effects Report #5443247-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2007. Male patient, 56 years of age, weighting 416.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anal fistula, perineal abscess, pyrexia, scrotal abscess, thrombocytopenia, white blood cell count abnormal, wound complication. Bevacizumab dosage: 10MG/M2 IV BOLUS. During the same period patient was treated with GEMCITABINE, ERLOTINIB D, ASPIRIN, CELEBREX, COMPAZINE, DIOVAN, GLIMEPIRIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5123379-4
Bevacizumab side effect was reported by a Health Professional from AUSTRALIA on Sept 19, 2006. Male patient, 54 years of age, weighting 134.5 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacteria blood identified, bacterial infection , disseminated intravascular coagulation, haematocrit decreased, pyrexia. Bevacizumab dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ERLOTINIB, GEMCITABINE, LAMIVUDINE, MAXOLON, PROCHLORPERAZINE, PANADOL, TRAMADOL, NEXIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5463067-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 05, 2007. Female patient, weighting 149.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, lethargy, malaise, metabolic acidosis, pyrexia, sinus tachycardia. Bevacizumab dosage: 340 MG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, GAVISCON, LISINOPRIL, DICLOFENAC, PARACETAMOL, OMEPRAZOLE, METOCLOPRAMIDE. Patient was hospitalized. Patient died on 03/10/2006.

Bevacizumab Side Effects Report #5690308-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 31, 2008. Female patient, weighting 138.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: catheter related infection, headache , implant site pain, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.


Bevacizumab Side Effects Report #5929938-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 21, 2008. Male patient, weighting 158.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: escherichia sepsis, pyrexia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, NAVOBAN, ACETAMINOPHEN, REGLAN, SORBOLENE, NEXIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5947528-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 27, 2008. Male patient, weighting 136.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia, sepsis . Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5950428-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 30, 2008. Male patient, weighting 178.6 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia, syncope. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, DOMPERIDONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5734163-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 31, 2007. Male patient, 71 years of age, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with XELODA, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5426153-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 16, 2007. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood pressure increased, oedema, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5472099-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 13, 2007. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood pressure increased, oedema, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with OXALIPLATIN, LYRICA, NORVASC, SYNTHROID, MORPHINE, NEXIUM, LORAZEPAM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6122088-2
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Mar 16, 2009. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chills, pyrexia. Bevacizumab dosage: 790 MG ONCE IV. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5494997-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 12, 2007. Female patient, weighting 229.3 lb, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cholangitis, pyrexia. Bevacizumab dosage: 1040 MG, UNK. During the same period patient was treated with GEMCITABINE, PROTONIX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5649791-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 20, 2008. Female patient was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia, vomiting. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, CAPECITABINE, GEMCITABINE, DICLOFENAC, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5730451-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 25, 2008. Female patient, weighting 224.9 lb, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cholangitis, pyrexia. Bevacizumab dosage: 1040 MG, UNK. During the same period patient was treated with GEMCITABINE, PROTONIX. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5306414-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 11, 2007. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pain , pyrexia. Bevacizumab dosage: 350 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5717771-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 14, 2008. Female patient, weighting 209.4 lb, was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arthralgia, haematuria, joint swelling, proteinuria, pyrexia, rash macular, viral infection . Bevacizumab dosage: 700 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PARACETAMOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5823797-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 10, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 397.5 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, TAVANIC. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5837218-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 23, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 397.5 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, TAVANIC. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5870957-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 22, 2008. Female patient, weighting 141.1 lb, was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5912841-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 23, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 397.5 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, TAVANIC. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5957387-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 06, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: lymphocele, pain , pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6049208-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 09, 2009. Female patient, weighting 141.1 lb, was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6049229-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 08, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: influenza, pyrexia. Bevacizumab dosage: 360 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6062752-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 19, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, LACTULOSE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6074230-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 27, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , lymphocele, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6104222-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 20, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, LACTULOSE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6106419-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 20, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: influenza, pyrexia. Bevacizumab dosage: 360 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5615812-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 22, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bevacizumab dosage: 523 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5656910-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2008. Female patient, weighting 221.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia. Bevacizumab dosage: 210 MG, UNK. During the same period patient was treated with ABRAXANE, ADVIL, MILK OF MAGNESIA, VITAMIN E, ZOFRAN, PHENERGAN, LORTAB, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5696340-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 31, 2008. Female patient, weighting 221.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ABRAXANE, ADVIL, MILK OF MAGNESIA, VITAMIN E, ZOFRAN, PHENERGAN, LORTAB, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5708586-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 02, 2008. Female patient, weighting 141.1 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5807638-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 26, 2008. Female patient, weighting 141.1 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: c-reactive protein increased, pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5819205-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 14, 2008. Female patient, weighting 221.6 lb, was diagnosed with ovarian cancer, pain , constipation , vitamin supplementation, nausea , diarrhoea and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ABRAXANE, ADVIL, MILK OF MAGNESIA, VITAMIN E, ZOFRAN, PHENERGAN, LORTAB, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6022205-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 17, 2008. Female patient was diagnosed with ovarian cancer, ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5354616-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 06, 2007. Male patient, 75 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer, bone marrow failure and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: decubitus ulcer, deep vein thrombosis , pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOTERE, OXALIPLATIN, DILAUDID, FILGRASTIM, DURAGESIC, TUSSINEX, PHENERGAN, HYCODAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5449362-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Male patient, 67 years of age, weighting 165.6 lb, was diagnosed with non-small cell lung cancer, neoplasm malignant, cough, stomatitis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemoptysis, pyrexia. Bevacizumab dosage: 762 MG, Q2W. During the same period patient was treated with CARDIZEM, DIGOXIN, ASPIRIN, TUSSINEX, LIDOCAINE VISCOUS, GLIPIZIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5464730-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 11, 2007. Male patient, 67 years of age, weighting 165.6 lb, was diagnosed with non-small cell lung cancer, neoplasm malignant, cough, stomatitis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemoptysis, pyrexia. Bevacizumab dosage: 762 MG, Q2W. During the same period patient was treated with CARDIZEM, DIGOXIN, ASPIRIN, TUSSINEX, LIDOCAINE VISCOUS, GLIPIZIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5252893-6
Bevacizumab side effect was reported by a Health Professional from JAPAN on Feb 11, 2007. Male patient, 60 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: c-reactive protein increased, chills, neutropenia, pyrexia, white blood cell count decreased. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DICLOFENAC, REBAMIPIDE, MAGNESIUM OXIDE, NIFEDIPINE, VALSARTAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5326235-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 01, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ALGINATE, TEPRENONE, MAGNESIUM SULPHATE, ETIZOLAM, ZOLMITRIPTAN, GUALENATE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5362153-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient, weighting 162.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cough, pyrexia. Bevacizumab dosage: 1177 MG, Q3W. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, COUMADIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5377473-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 20, 2007. Male patient, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, febrile bone marrow aplasia, jaundice , pyrexia. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, VINORELBINE, FENTANYL, FORLAX, ACTISKENAN, NEXIUM, LEXOMIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5384855-2
Bevacizumab side effect was reported by a Physician from GERMANY on July 03, 2007. Female patient, weighting 112.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 795 MG, Q3W. During the same period patient was treated with VINORELBIN, CARBOPLATIN, CIPROFLOXACIN, IBUPROFEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5428076-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 16, 2007. Male patient, weighting 135.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: myocardial infarction, myocarditis, pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PEMETREXED. Patient was hospitalized. Patient died on 08/10/2007.

Bevacizumab Side Effects Report #5452985-2
Bevacizumab side effect was reported by a Physician from NETHERLANDS on Aug 30, 2007. Female patient, weighting 92.59 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PAROXETINE, PANTOPRAZOLE, SPIRIVA, GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5471951-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 14, 2007. Male patient, weighting 145.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, fatigue, pyrexia. Bevacizumab dosage: 960 MG, UNK. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5483069-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 27, 2007. Female patient, weighting 92.37 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: c-reactive protein increased, neutrophil percentage decreased, pyrexia, white blood cell count decreased. Bevacizumab dosage: 629 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, OXYCODONE, FENTANYL, METOCLOPRAMIDE, TRIAMCINOLONE, PROCHLORPERAZINE, LOXOPROFEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5488503-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 02, 2007. Female patient, weighting 92.37 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 629 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, OXYCODONE, FENTANYL, METOCLOPRAMIDE, TRIAMCINOLONE, PROCHLORPERAZINE, LOXOPROFEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5521076-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 05, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: infection , pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, STILNOX. Patient was hospitalized. Patient died on 11/02/2007.

Bevacizumab Side Effects Report #5577826-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 17, 2007. Female patient, weighting 135.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 122.5 MG, UNK. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5578275-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 17, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 855 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, ZOLOFT, CHLORIDE, PLATELETS. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5717059-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 09, 2008. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with BISOPROLOL FUMARATE, COZAAR, AMLODIPINE, SPIRON, FUROSEMIDE, SIMVASTATIN, NEXIUM, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5722379-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 14, 2008. Male patient, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 1000 MG, Q3W. During the same period patient was treated with PACLITAXEL, CISPLATIN, FORMOTEROL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5725717-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 22, 2008. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, epistaxis, fatigue, neutrophil count decreased, pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with BISOPROLOL FUMARATE, COZAAR, AMLODIPINE, SPIRON, FUROSEMIDE, SIMVASTATIN, NEXIUM, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5740919-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 09, 2008. Male patient, weighting 230.0 lb, was diagnosed with non-small cell lung cancer, prophylaxis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: leukocytosis, pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5745846-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 12, 2008. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, neutrophil count decreased, pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with BISOPROLOL FUMARATE, COZAAR, AMLODIPINE, SPIRON, FUROSEMIDE, SIMVASTATIN, NEXIUM, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5758676-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 21, 2008. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: epistaxis, fatigue, neutrophil count decreased, pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with BISOPROLOL FUMARATE, COZAAR, AMLODIPINE, SPIRON, FUROSEMIDE, SIMVASTATIN, NEXIUM, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5777923-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 03, 2008. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, neutrophil count decreased, pyrexia, white blood cell count decreased. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with BISOPROLOL FUMARATE, COZAAR, AMLODIPINE, SPIRON, FUROSEMIDE, SIMVASTATIN, NEXIUM, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5781179-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 12, 2008. Male patient, weighting 230.0 lb, was diagnosed with non-small cell lung cancer, prophylaxis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: leukocytosis, pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5844088-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 29, 2008. Male patient, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 1000 MG, Q3W. During the same period patient was treated with PACLITAXEL, CISPLATIN, FORMOTEROL FUMARATE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5875223-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 26, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bevacizumab dosage: 1100 MG, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, NEUPOGEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5914159-8
Bevacizumab side effect was reported by a Physician from NETHERLANDS on Sept 24, 2008. Female patient, weighting 92.59 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PAROXETINE, PANTOZOL, SPIRIVA, GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5949220-5
Bevacizumab side effect was reported by a Physician from NETHERLANDS on Oct 29, 2008. Female patient, weighting 92.59 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CISPLATIN, PAROXETINE, PANTOZOL, SPIRIVA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6016846-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 08, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 15 MG/KG, QD. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6016850-4
Bevacizumab side effect was reported by a Physician from NETHERLANDS on Nov 25, 2008. Female patient, weighting 92.59 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CISPLATIN, PAROXETINE, PANTOZOL, SPIRIVA. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6016878-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 24, 2008. Male patient, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chills, cough, pyrexia. Bevacizumab dosage: 860 MG, Q14D. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6023788-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 16, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia pneumococcal, pyrexia. Bevacizumab dosage: 15 MG/KG, QD. During the same period patient was treated with ERLOTINIB, INSULIN, FUROSEMIDE, ASPIRIN, RAMIPRIL, METOPROLOL, THEOPHYLLINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6053888-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2009. Male patient, weighting 216.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arthralgia, diarrhoea, dysuria, hypophagia, nausea , neutropenia, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6082536-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 10, 2009. Male patient, weighting 230.0 lb, was diagnosed with non-small cell lung cancer, prophylaxis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: leukocytosis, pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6126856-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2009. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, pyrexia. Bevacizumab dosage: 10 ML/KG, DAYS 1+15. During the same period patient was treated with PEMETREXED, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5507065-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 31, 2007. Male patient, weighting 130.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 15 MG/KG, WKS 1 + 4. During the same period patient was treated with ERLOTINIB, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5725819-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 23, 2008. Female patient, weighting 147.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6037712-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 30, 2008. Male patient was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anal fissure, anorectal disorder, febrile bone marrow aplasia, ill-defined disorder, pyrexia, skin infection, subcutaneous nodule, viral upper respiratory tract infection. Bevacizumab dosage: 270 MG, Q21D. During the same period patient was treated with DACTINOMYCIN, DOXORUBICIN, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6045615-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 06, 2009. Male patient was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, pyrexia. Bevacizumab dosage: 270 MG, Q21D. During the same period patient was treated with DACTINOMYCIN, DOXORUBICIN, IFOSFAMIDE, VINCRISTINE. Patient recovered.

Bevacizumab Side Effects Report #6052299-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 12, 2009. Male patient was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, pyrexia. Bevacizumab dosage: 270 MG, Q21D. During the same period patient was treated with DACTINOMYCIN, DOXORUBICIN, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6067015-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 21, 2009. Male patient was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, pyrexia. Bevacizumab dosage: 270 MG, Q21D. During the same period patient was treated with DACTINOMYCIN, DOXORUBICIN, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5741032-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 08, 2008. Male patient, 57 years of age, was diagnosed with nasopharyngeal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5764219-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 02, 2008. Male patient, 57 years of age, was diagnosed with nasopharyngeal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ototoxicity, pyrexia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, CISPLATIN, ALLOPURINOL, LEXAPRO, KYTRIL, REGLAN, ATIVAN, RANITIDINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5800867-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 27, 2008. Male patient, 57 years of age, was diagnosed with nasopharyngeal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, CISPLATIN, ALLOPURINOL, LEXAPRO, KYTRIL, REGLAN, ATIVAN, RANITIDINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5761915-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 22, 2008. Female patient, 58 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, pyrexia. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with INTERFERON ALFA, SKENAN, ACTISKENAN, INNOHEP, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, LYRICA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5798643-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 20, 2008. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, pyrexia. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with INTERFERON ALFA, SKENAN, MORPHINE, INNOHEP, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, LYRICA, TANAKAN, VASTAREL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5879749-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 28, 2008. Male patient was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anxiety , pyrexia, respiratory failure, spinal cord compression, streptococcal infection , urinary tract infection . Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with TEMSIROLIMUS, TAHOR, LOVENOX, ALDACTONE, LIPANTHYL, ZOMETA. Patient was hospitalized. Patient died on 08/11/2008.

Bevacizumab Side Effects Report #6004992-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 02, 2008. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia. Bevacizumab dosage: 530 MG, UNK. During the same period patient was treated with TEMSIROLIMUS. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5847128-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 31, 2008. Male patient was diagnosed with metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diabetes mellitus, gastroenteritis salmonella, hypertension, pyrexia. Bevacizumab dosage: 800 MG, Q2W. During the same period patient was treated with TEMODAL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5852708-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 08, 2008. Male patient was diagnosed with metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diabetes mellitus, gastroenteritis salmonella, hypertension, pyrexia. Bevacizumab dosage: 800 MG, Q2W. During the same period patient was treated with TEMODAL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5528262-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 20, 2007. Male patient was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal obstruction, neutropenia, pyrexia. Bevacizumab dosage: 10 MG/M2, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5588813-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 02, 2008. Male patient, weighting 174.2 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ileus, neutropenia, pyrexia. Bevacizumab dosage: 10 MG/M2, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.